{"Age":71,"Drug":["Prednisone; Abiraterone"],"Gender":"M","Gleason":8,"Histology":["Adenocarcinoma"],"Mutations":[],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca96a"},"case_ID":"DTB-003"}
{"Age":60,"Date_of_CRPC":{"$date":"2013-01-16T00:00:00.000Z"},"Drug":["Docetaxel","Carboplatin; Docetaxel"],"Gender":"M","Gleason":9,"Histology":["Adenocarcinoma"],"Mutations":["FGER1; TP53"],"Status":"OFF STUDY","_id":{"$oid":"56074312f1f77c0a80eca96b"},"case_ID":"DTB-005"}
{"Age":61,"Date_of_CRPC":{"$date":"2012-02-15T00:00:00.000Z"},"Drug":["Prednisone; Mitoxantrone; Cabazitaxel"],"Gender":"M","Gleason":6,"Histology":["No Definite Tumor"],"Mutations":[],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca96c"},"case_ID":"DTB-007"}
{"Age":75,"Date_of_CRPC":{"$date":"2012-07-27T00:00:00.000Z"},"Drug":["Abiraterone; Prednisone"],"Gender":"M","Gleason":9,"Histology":["Small Cell"],"Mutations":[],"Status":"ON FOLLOW UP","_id":{"$oid":"56074312f1f77c0a80eca96d"},"case_ID":"DTB-008"}
{"Age":63,"Drug":["Docetaxel"],"Gender":"M","Gleason":8,"Histology":["Other"],"Mutations":["None"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca96e"},"case_ID":"DTB-009"}
{"Age":71,"Date_of_CRPC":{"$date":"2004-06-01T00:00:00.000Z"},"Drug":["Carboplatin; Docetaxel"],"Gender":"M","Gleason":7,"Histology":["Adenocarcinoma"],"Mutations":["None"],"Status":"OFF STUDY","_id":{"$oid":"56074312f1f77c0a80eca96f"},"case_ID":"DTB-004"}
{"Age":68,"Date_of_CRPC":{"$date":"2012-03-06T00:00:00.000Z"},"Drug":["Abiraterone; Prednisone"],"Gender":"M","Gleason":7,"Histology":["Small Cell"],"Mutations":["EGFR; TP53"],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca970"},"case_ID":"DTB-011"}
{"Age":61,"Drug":["Abiraterone; Prednisone","Docetaxel"],"Gender":"M","Gleason":7,"Histology":["No Definite Tumor","Other"],"Mutations":["TP53"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca971"},"case_ID":"DTB-010"}
{"Age":65,"Date_of_CRPC":{"$date":"2012-09-20T00:00:00.000Z"},"Drug":["Abiraterone; Prednisone"],"Gender":"M","Gleason":7,"Histology":["No Definite Tumor"],"Mutations":[],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca972"},"case_ID":"DTB-013"}
{"Age":69,"Drug":["Abiraterone; Prednisone"],"Gender":"M","Gleason":6,"Histology":["No Definite Tumor","Other"],"Mutations":["None"],"Status":"ON FOLLOW UP","_id":{"$oid":"56074312f1f77c0a80eca973"},"case_ID":"DTB-016"}
{"Age":70,"Date_of_CRPC":{"$date":"2012-01-25T00:00:00.000Z"},"Drug":[],"Gender":"M","Gleason":8,"Histology":["Adenocarcinoma"],"Mutations":["PIK3R1"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca974"},"case_ID":"DTB-020"}
{"Age":66,"Drug":["Abiraterone; Prednisone","Alpharadin; Docetaxel"],"Gender":"M","Gleason":8,"Histology":["Other","Adenocarcinoma"],"Mutations":["TP53","None"],"Status":"OFF TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca975"},"case_ID":"DTB-019"}
{"Age":55,"Drug":["Abiraterone; Prednisone","Selinexor"],"Gender":"M","Gleason":9,"Histology":["Other","No Definite Tumor"],"Mutations":["TP53"],"Status":"ON FOLLOW UP","_id":{"$oid":"56074312f1f77c0a80eca976"},"case_ID":"DTB-018"}
{"Age":74,"Drug":["Abiraterone; Prednisone"],"Gender":"M","Gleason":8,"Histology":["Adenocarcinoma"],"Mutations":[],"Status":"ON FOLLOW UP","_id":{"$oid":"56074312f1f77c0a80eca977"},"case_ID":"DTB-015"}
{"Age":57,"Drug":["Abiraterone; Prednisone"],"Gender":"M","Gleason":7,"Histology":["No Definite Tumor"],"Mutations":[],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca978"},"case_ID":"DTB-021"}
{"Age":65,"Date_of_CRPC":{"$date":"2012-09-14T00:00:00.000Z"},"Drug":["Prednisone; Abiraterone"],"Gender":"M","Gleason":7,"Histology":["Adenocarcinoma","Adenocarcinoma"],"Mutations":["None","None"],"Status":"ON FOLLOW UP","_id":{"$oid":"56074312f1f77c0a80eca979"},"case_ID":"DTB-014"}
{"Age":54,"Drug":["Xofigo"],"Gender":"M","Gleason":8,"Histology":["Adenocarcinoma"],"Mutations":[],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca97a"},"case_ID":"DTB-023"}
{"Age":74,"Gender":"M","Gleason":7,"Status":"OFF STUDY","_id":{"$oid":"56074312f1f77c0a80eca97b"},"case_ID":"DTB-025"}
{"Age":77,"Date_of_CRPC":{"$date":"2012-07-23T00:00:00.000Z"},"Drug":["Docetaxel","Enzalutamide"],"Gender":"M","Gleason":9,"Histology":["Adenocarcinoma"],"Mutations":[],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca97c"},"case_ID":"DTB-024"}
{"Age":61,"Drug":["Cabazitaxel; Mitoxantrone; Dexamethasone; Prednisone"],"Gender":"M","Gleason":8,"Histology":["No Definite Tumor","No Definite Tumor"],"Mutations":[],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca97d"},"case_ID":"DTB-026"}
{"Age":72,"Date_of_CRPC":{"$date":"2012-09-15T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":10,"Histology":["No Definite Tumor"],"Mutations":[],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca97e"},"case_ID":"DTB-027"}
{"Age":61,"Date_of_CRPC":{"$date":"2010-05-01T00:00:00.000Z"},"Drug":["Radium-223 chloride"],"Gender":"M","Gleason":8,"Histology":["No Definite Tumor"],"Mutations":[],"Status":"OFF STUDY","_id":{"$oid":"56074312f1f77c0a80eca97f"},"case_ID":"DTB-028"}
{"Age":88,"Date_of_CRPC":{"$date":"2012-08-20T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":6,"Histology":["Adenocarcinoma"],"Mutations":[],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca980"},"case_ID":"DTB-035"}
{"Age":69,"Date_of_CRPC":{"$date":"2013-03-05T00:00:00.000Z"},"Drug":["Prednisone; Abiraterone","Enzalutamide"],"Gender":"M","Gleason":8,"Histology":["Adenocarcinoma"],"Mutations":[],"Status":"ON FOLLOW UP","_id":{"$oid":"56074312f1f77c0a80eca981"},"case_ID":"DTB-022"}
{"Age":49,"Date_of_CRPC":{"$date":"2012-11-19T00:00:00.000Z"},"Drug":["Docetaxel; MLN8237"],"Gender":"M","Gleason":9,"Histology":["Small Cell"],"Mutations":[],"Status":"OFF STUDY","_id":{"$oid":"56074312f1f77c0a80eca982"},"case_ID":"DTB-031"}
{"Age":77,"Date_of_CRPC":{"$date":"2010-11-11T00:00:00.000Z"},"Drug":["Docetaxel"],"Gender":"M","Gleason":7,"Histology":["Small Cell"],"Mutations":[],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca983"},"case_ID":"DTB-032"}
{"Age":69,"Date_of_CRPC":{"$date":"2007-12-01T00:00:00.000Z"},"Drug":["Carboplatin; Docetaxel"],"Gender":"M","Gleason":7,"Histology":["Other"],"Mutations":["TP53"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca984"},"case_ID":"DTB-034"}
{"Age":75,"Date_of_CRPC":{"$date":"2007-10-15T00:00:00.000Z"},"Drug":["Abiraterone; Prednisone"],"Gender":"M","Gleason":7,"Histology":["Other"],"Mutations":[],"Status":"ON FOLLOW UP","_id":{"$oid":"56074312f1f77c0a80eca985"},"case_ID":"DTB-030"}
{"Age":74,"Date_of_CRPC":{"$date":"2012-05-09T00:00:00.000Z"},"Drug":[],"Gender":"M","Histology":["Small Cell"],"Mutations":["TP53"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca986"},"case_ID":"DTB-036"}
{"Age":55,"Date_of_CRPC":{"$date":"2013-03-01T00:00:00.000Z"},"Drug":["Docetaxel"],"Gender":"M","Gleason":9,"Histology":["Small Cell"],"Mutations":["RBI"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca987"},"case_ID":"DTB-043"}
{"Age":64,"Drug":["Xofigo"],"Gender":"M","Gleason":6,"Histology":["Small Cell"],"Mutations":[],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca988"},"case_ID":"DTB-037"}
{"Age":77,"Date_of_CRPC":{"$date":"1996-01-01T00:00:00.000Z"},"Drug":["Prednisone; Abiraterone"],"Gender":"M","Gleason":8,"Histology":["Adenocarcinoma"],"Mutations":["None"],"Status":"ON FOLLOW UP","_id":{"$oid":"56074312f1f77c0a80eca989"},"case_ID":"DTB-038"}
{"Age":71,"Date_of_CRPC":{"$date":"2011-03-18T00:00:00.000Z"},"Drug":["Docetaxel; Phenelzine"],"Gender":"M","Gleason":8,"Histology":["Adenocarcinoma"],"Mutations":["TSC2"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca98a"},"case_ID":"DTB-039"}
{"Age":57,"Date_of_CRPC":{"$date":"2013-08-21T00:00:00.000Z"},"Drug":["Cisplatin/Etoposide"],"Gender":"M","Gleason":9,"Histology":["Small Cell"],"Mutations":["TP53; PTEN"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca98b"},"case_ID":"DTB-040"}
{"Age":64,"Date_of_CRPC":{"$date":"2011-05-01T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":8,"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca98c"},"case_ID":"DTB-042"}
{"Age":71,"Drug":["Abiraterone; Prednisone"],"Gender":"M","Gleason":10,"Histology":["No Definite Tumor"],"Mutations":[],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca98d"},"case_ID":"DTB-041"}
{"Age":84,"Date_of_CRPC":{"$date":"2009-01-01T00:00:00.000Z"},"Drug":["Decadron; Cytoxan","Radium-223 chloride","Mitoxantrone"],"Gender":"M","Gleason":8,"Histology":["No Definite Tumor","No Definite Tumor"],"Mutations":[],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca98e"},"case_ID":"DTB-033"}
{"Age":72,"Date_of_CRPC":{"$date":"2012-06-01T00:00:00.000Z"},"Drug":["CC-115"],"Gender":"M","Gleason":7,"Histology":["Other"],"Mutations":["PTEN"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca98f"},"case_ID":"DTB-044"}
{"Age":66,"Date_of_CRPC":{"$date":"2013-04-18T00:00:00.000Z"},"Drug":["Docetaxel","Abiraterone; Prednisone"],"Gender":"M","Histology":["No Definite Tumor"],"Mutations":[],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca990"},"case_ID":"DTB-045"}
{"Age":66,"Date_of_CRPC":{"$date":"2011-11-14T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":8,"Histology":["Adenocarcinoma"],"Mutations":["PIK3CA; PTEN"],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca991"},"case_ID":"DTB-046"}
{"Age":73,"Date_of_CRPC":{"$date":"2008-07-01T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":6,"Histology":["No Definite Tumor"],"Mutations":[],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca992"},"case_ID":"DTB-047"}
{"Age":69,"Date_of_CRPC":{"$date":"2012-04-09T00:00:00.000Z"},"Drug":["Docetaxel; Carboplatin"],"Gender":"M","Gleason":6,"Histology":["No Definite Tumor"],"Mutations":[],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca993"},"case_ID":"DTB-049"}
{"Age":67,"Date_of_CRPC":{"$date":"2012-08-07T00:00:00.000Z"},"Drug":[],"Gender":"M","Gleason":8,"Histology":["Adenocarcinoma"],"Mutations":["None"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca994"},"case_ID":"DTB-050"}
{"Age":67,"Date_of_CRPC":{"$date":"2012-05-21T00:00:00.000Z"},"Drug":["Dexamethasone; Cabazitaxel; Mitoxantrone"],"Gender":"M","Gleason":7,"Histology":["No Definite Tumor"],"Mutations":[],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca995"},"case_ID":"DTB-052"}
{"Age":75,"Date_of_CRPC":{"$date":"2012-12-07T00:00:00.000Z"},"Drug":["Enzalutamide; Xofigo"],"Gender":"M","Gleason":8,"Histology":["Adenocarcinoma"],"Mutations":[],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca996"},"case_ID":"DTB-053"}
{"Age":75,"Date_of_CRPC":{"$date":"2011-01-01T00:00:00.000Z"},"Drug":["Prednisone; Abiraterone","Ketoconazole"],"Gender":"M","Gleason":7,"Histology":["No Definite Tumor","Adenocarcinoma"],"Mutations":["PTEN; TP53"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca997"},"case_ID":"DTB-055"}
{"Age":72,"Date_of_CRPC":{"$date":"2012-03-09T00:00:00.000Z"},"Drug":["Cabazitaxel; Custirsen","Enzalutamide","Cyclophosphamide; Dexamethasone","Abiraterone; Prednisone","Abiraterone; Melphalan/Prednisone"],"Gender":"M","Gleason":6,"Histology":["No Definite Tumor"],"Mutations":[],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca998"},"case_ID":"DTB-056"}
{"Age":68,"Drug":["Mitoxantrone"],"Gender":"M","Gleason":7,"Histology":["Adenocarcinoma"],"Mutations":[],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca999"},"case_ID":"DTB-058"}
{"Age":65,"Date_of_CRPC":{"$date":"2013-07-15T00:00:00.000Z"},"Drug":["Prednisone; Docetaxel","Enzalutamide"],"Gender":"M","Gleason":9,"Histology":["Adenocarcinoma"],"Mutations":["None"],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca99a"},"case_ID":"DTB-057"}
{"Age":64,"Date_of_CRPC":{"$date":"2005-01-01T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":7,"Histology":["Small Cell"],"Mutations":["TP53"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca99b"},"case_ID":"DTB-059"}
{"Age":82,"Date_of_CRPC":{"$date":"2010-04-27T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Histology":["Adenocarcinoma","Adenocarcinoma"],"Mutations":["None","None"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca99c"},"case_ID":"DTB-060"}
{"Age":68,"Date_of_CRPC":{"$date":"2013-04-25T00:00:00.000Z"},"Drug":["Docetaxel"],"Gender":"M","Gleason":7,"Histology":["Small Cell"],"Mutations":["TSC1; NOTCH1; TP53"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca99d"},"case_ID":"DTB-061"}
{"Age":71,"Date_of_CRPC":{"$date":"2012-08-01T00:00:00.000Z"},"Drug":["Prednisone; Docetaxel","Radium-223 chloride","Enzalutamide"],"Gender":"M","Gleason":9,"Histology":["Adenocarcinoma"],"Mutations":[],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca99e"},"case_ID":"DTB-062"}
{"Age":62,"Date_of_CRPC":{"$date":"2005-01-01T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":8,"Histology":["Adenocarcinoma"],"Mutations":["TSC2"],"Status":"ON FOLLOW UP","_id":{"$oid":"56074312f1f77c0a80eca99f"},"case_ID":"DTB-064"}
{"Age":65,"Date_of_CRPC":{"$date":"2011-08-01T00:00:00.000Z"},"Drug":["Enzalutamide","Abiraterone; Prednisone","MEK-162","Provenge"],"Gender":"M","Gleason":9,"Histology":["Adenocarcinoma","Other"],"Mutations":["HRAS; TP53; AKT1","TP53; AKT1; HRAS"],"Status":"ON FOLLOW UP","_id":{"$oid":"56074312f1f77c0a80eca9a0"},"case_ID":"DTB-063"}
{"Age":69,"Date_of_CRPC":{"$date":"2009-09-11T00:00:00.000Z"},"Drug":["Mitoxantrone"],"Gender":"M","Histology":["Small Cell"],"Mutations":[],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca9a1"},"case_ID":"DTB-065"}
{"Age":73,"Date_of_CRPC":{"$date":"2010-07-07T00:00:00.000Z"},"Drug":["Abiraterone; Prednisone"],"Gender":"M","Gleason":10,"Histology":["Adenocarcinoma","Other"],"Mutations":["None"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca9a2"},"case_ID":"DTB-067"}
{"Age":70,"Date_of_CRPC":{"$date":"2012-05-23T00:00:00.000Z"},"Drug":["Itraconazole","Carboplatin; Docetaxel"],"Gender":"M","Gleason":7,"Histology":["Adenocarcinoma"],"Mutations":["None"],"Status":"OFF STUDY","_id":{"$oid":"56074312f1f77c0a80eca9a3"},"case_ID":"DTB-068"}
{"Age":71,"Date_of_CRPC":{"$date":"2012-04-01T00:00:00.000Z"},"Drug":[],"Gender":"M","Gleason":6,"Histology":["No Definite Tumor"],"Mutations":["None"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca9a4"},"case_ID":"DTB-075"}
{"Age":76,"Date_of_CRPC":{"$date":"2011-09-29T00:00:00.000Z"},"Drug":["Radium-223 chloride"],"Gender":"M","Gleason":7,"Histology":["No Definite Tumor"],"Mutations":[],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca9a5"},"case_ID":"DTB-070"}
{"Age":70,"Date_of_CRPC":{"$date":"2012-11-29T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":7,"Histology":["Adenocarcinoma"],"Mutations":[],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9a6"},"case_ID":"DTB-077"}
{"Age":66,"Gender":"M","Gleason":9,"Histology":[],"Mutations":[],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca9a7"},"case_ID":"DTB-072"}
{"Age":67,"Date_of_CRPC":{"$date":"2012-05-08T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":10,"Histology":["Other","Other"],"Mutations":["TP53","TP53"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca9a8"},"case_ID":"DTB-073"}
{"Age":76,"Date_of_CRPC":{"$date":"2008-04-01T00:00:00.000Z"},"Drug":[],"Gender":"M","Gleason":8,"Histology":["No Definite Tumor"],"Mutations":[],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9a9"},"case_ID":"DTB-074"}
{"Age":73,"Date_of_CRPC":{"$date":"2011-07-09T00:00:00.000Z"},"Drug":["Cabazitaxel"],"Gender":"M","Gleason":7,"Histology":["Small Cell"],"Mutations":["TP53; PIK3CA"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca9aa"},"case_ID":"DTB-069"}
{"Age":79,"Date_of_CRPC":{"$date":"2009-05-28T00:00:00.000Z"},"Drug":["Docetaxel"],"Gender":"M","Gleason":7,"Histology":["Adenocarcinoma"],"Mutations":["TP53"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca9ab"},"case_ID":"DTB-076"}
{"Age":66,"Date_of_CRPC":{"$date":"2014-01-06T00:00:00.000Z"},"Drug":["Abiraterone"],"Gender":"M","Gleason":9,"Histology":["Small Cell"],"Mutations":["GNAS; NFI; TP53"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca9ac"},"case_ID":"DTB-071"}
{"Age":89,"Date_of_CRPC":{"$date":"2011-10-01T00:00:00.000Z"},"Drug":["Xofigo"],"Gender":"M","Gleason":7,"Histology":["No Definite Tumor"],"Mutations":[],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca9ad"},"case_ID":"DTB-078"}
{"Age":78,"Date_of_CRPC":{"$date":"2010-03-16T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":7,"Histology":["No Definite Tumor"],"Mutations":[],"Status":"ON FOLLOW UP","_id":{"$oid":"56074312f1f77c0a80eca9ae"},"case_ID":"DTB-079"}
{"Age":59,"Date_of_CRPC":{"$date":"2014-02-19T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":9,"Histology":["Small Cell","Adenocarcinoma"],"Mutations":["PTEN","PTEN"],"Status":"ON FOLLOW UP","_id":{"$oid":"56074312f1f77c0a80eca9af"},"case_ID":"DTB-080"}
{"Age":53,"Date_of_CRPC":{"$date":"2011-10-26T00:00:00.000Z"},"Drug":["Etoposide; Cisplatin"],"Gender":"M","Gleason":9,"Histology":["Adenocarcinoma"],"Mutations":[],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca9b0"},"case_ID":"DTB-081"}
{"Age":62,"Date_of_CRPC":{"$date":"2011-08-27T00:00:00.000Z"},"Drug":["Provenge","Ipilimumab"],"Gender":"M","Gleason":9,"Histology":["Adenocarcinoma"],"Mutations":["TP53"],"Status":"OFF STUDY","_id":{"$oid":"56074312f1f77c0a80eca9b1"},"case_ID":"DTB-082"}
{"Age":75,"Date_of_CRPC":{"$date":"2010-03-01T00:00:00.000Z"},"Drug":["Cabazitaxel; Prednisone","Cytoxan"],"Gender":"M","Gleason":7,"Histology":["Small Cell"],"Mutations":["TP53"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca9b2"},"case_ID":"DTB-083"}
{"Age":79,"Date_of_CRPC":{"$date":"2014-03-18T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":9,"Histology":["Adenocarcinoma"],"Mutations":["HRAS; CDKN2A; TP53"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca9b3"},"case_ID":"DTB-091"}
{"Age":74,"Date_of_CRPC":{"$date":"2011-01-07T00:00:00.000Z"},"Drug":["Docetaxel"],"Gender":"M","Gleason":6,"Histology":["Other"],"Mutations":["MET; TP53"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca9b4"},"case_ID":"DTB-085"}
{"Age":72,"Date_of_CRPC":{"$date":"2013-05-26T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Histology":["No Definite Tumor"],"Mutations":[],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca9b5"},"case_ID":"DTB-086"}
{"Age":66,"Drug":["Enzalutamide"],"Gender":"M","Gleason":9,"Histology":["No Definite Tumor"],"Mutations":[],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9b6"},"case_ID":"DTB-087"}
{"Age":73,"Date_of_CRPC":{"$date":"2014-03-18T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":7,"Histology":["Adenocarcinoma"],"Mutations":["TP53"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca9b7"},"case_ID":"DTB-088"}
{"Age":79,"Date_of_CRPC":{"$date":"2012-01-24T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":9,"Histology":["Adenocarcinoma","Adenocarcinoma"],"Mutations":["None","TP53"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca9b8"},"case_ID":"DTB-089"}
{"Age":45,"Drug":["Xofigo","Enzalutamide"],"Gender":"M","Gleason":10,"Histology":["Adenocarcinoma","Other"],"Mutations":["None","PTEN; TP53"],"Status":"ON FOLLOW UP","_id":{"$oid":"56074312f1f77c0a80eca9b9"},"case_ID":"DTB-090"}
{"Age":59,"Date_of_CRPC":{"$date":"2012-07-17T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":7,"Histology":["No Definite Tumor"],"Mutations":[],"Status":"ON FOLLOW UP","_id":{"$oid":"56074312f1f77c0a80eca9ba"},"case_ID":"DTB-084"}
{"Age":67,"Date_of_CRPC":{"$date":"2013-05-14T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":9,"Histology":["Adenocarcinoma"],"Mutations":["TP53"],"Status":"ON FOLLOW UP","_id":{"$oid":"56074312f1f77c0a80eca9bb"},"case_ID":"DTB-092"}
{"Age":73,"Drug":[],"Gender":"M","Histology":["Adenocarcinoma"],"Mutations":[],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9bc"},"case_ID":"DTB-093"}
{"Age":67,"Drug":["Provenge"],"Gender":"M","Gleason":7,"Histology":["Adenocarcinoma","Adenocarcinoma"],"Mutations":["RBI","RBI"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca9bd"},"case_ID":"DTB-095"}
{"Age":65,"Date_of_CRPC":{"$date":"2009-11-02T00:00:00.000Z"},"Drug":["Enzalutamide","Prednisone; Abiraterone"],"Gender":"M","Histology":[],"Mutations":[],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9be"},"case_ID":"DTB-094"}
{"Age":70,"Date_of_CRPC":{"$date":"2012-08-30T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":9,"Histology":["Adenocarcinoma","Adenocarcinoma"],"Mutations":["None"],"Status":"ON FOLLOW UP","_id":{"$oid":"56074312f1f77c0a80eca9bf"},"case_ID":"DTB-096"}
{"Age":73,"Date_of_CRPC":{"$date":"2013-12-01T00:00:00.000Z"},"Drug":["BMN-673"],"Gender":"M","Gleason":6,"Histology":["Adenocarcinoma","Other"],"Mutations":["NFI","NFI"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca9c0"},"case_ID":"DTB-097"}
{"Age":58,"Date_of_CRPC":{"$date":"2014-06-01T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":8,"Histology":["Adenocarcinoma"],"Mutations":["None"],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9c1"},"case_ID":"DTB-098"}
{"Age":66,"Date_of_CRPC":{"$date":"2012-11-01T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":7,"Histology":["Adenocarcinoma"],"Mutations":["None"],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9c2"},"case_ID":"DTB-099"}
{"Age":68,"Drug":["Mitoxantrone"],"Gender":"M","Gleason":8,"Histology":["Adenocarcinoma"],"Mutations":["PTEN; TP53"],"Status":"ON FOLLOW UP","_id":{"$oid":"56074312f1f77c0a80eca9c3"},"case_ID":"DTB-100"}
{"Age":74,"Drug":["Xofigo","Enzalutamide"],"Gender":"M","Gleason":7,"Histology":["Adenocarcinoma"],"Mutations":[],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca9c4"},"case_ID":"DTB-101"}
{"Age":85,"Date_of_CRPC":{"$date":"2008-07-11T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":9,"Histology":["Other"],"Mutations":["TP53"],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9c5"},"case_ID":"DTB-102"}
{"Age":67,"Date_of_CRPC":{"$date":"2010-12-01T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":9,"Histology":["Other","Other"],"Mutations":["RBI; FGER3; NOTCH1","NOTCH1; FGER3; RBI"],"Status":"ON FOLLOW UP","_id":{"$oid":"56074312f1f77c0a80eca9c6"},"case_ID":"DTB-103"}
{"Age":82,"Drug":["Abiraterone; Prednisone"],"Gender":"M","Gleason":6,"Histology":["Other"],"Mutations":["ERBB2; DDR2; PTEN; TP53"],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9c7"},"case_ID":"DTB-104"}
{"Age":63,"Drug":["Enzalutamide","Xofigo"],"Gender":"M","Histology":["Other"],"Mutations":[],"Status":"OFF STUDY","_id":{"$oid":"56074312f1f77c0a80eca9c8"},"case_ID":"DTB-106"}
{"Age":63,"Date_of_CRPC":{"$date":"2012-08-16T00:00:00.000Z"},"Drug":["Xofigo","Enzalutamide"],"Gender":"M","Gleason":7,"Histology":["Other"],"Mutations":[],"Status":"OFF STUDY","_id":{"$oid":"56074312f1f77c0a80eca9c9"},"case_ID":"DTB-105"}
{"Age":66,"Date_of_CRPC":{"$date":"2003-06-16T00:00:00.000Z"},"Drug":[],"Gender":"M","Gleason":9,"Histology":["Other"],"Mutations":[],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9ca"},"case_ID":"DTB-107"}
{"Age":63,"Date_of_CRPC":{"$date":"2012-06-01T00:00:00.000Z"},"Drug":["Docetaxel"],"Gender":"M","Gleason":6,"Histology":["Other"],"Mutations":["CDKN2A"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca9cb"},"case_ID":"DTB-108"}
{"Age":61,"Drug":["Sipuleucel-T"],"Gender":"M","Gleason":9,"Histology":["Other"],"Mutations":[],"Status":"OFF STUDY","_id":{"$oid":"56074312f1f77c0a80eca9cc"},"case_ID":"DTB-109"}
{"Age":66,"Drug":["Docetaxel; Prednisone"],"Gender":"M","Gleason":8,"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9cd"},"case_ID":"DTB-110"}
{"Age":69,"Date_of_CRPC":{"$date":"2013-04-30T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":7,"Histology":["Adenocarcinoma","Other"],"Mutations":["TP53; CDKN2A; KDR","TP53; KDR; CDKN2A"],"Status":"ON FOLLOW UP","_id":{"$oid":"56074312f1f77c0a80eca9ce"},"case_ID":"DTB-111"}
{"Age":70,"Drug":["Prednisone; Abiraterone"],"Gender":"M","Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9cf"},"case_ID":"DTB-113"}
{"Age":76,"Date_of_CRPC":{"$date":"2008-10-14T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":8,"Histology":["Adenocarcinoma"],"Mutations":["NOTCH1; TP53; ALK"],"Status":"OFF STUDY","_id":{"$oid":"56074312f1f77c0a80eca9d0"},"case_ID":"DTB-112"}
{"Age":76,"Drug":["Enzalutamide"],"Gender":"M","Histology":["Adenocarcinoma"],"Mutations":[],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca9d1"},"case_ID":"DTB-114"}
{"Age":90,"Date_of_CRPC":{"$date":"2014-02-01T00:00:00.000Z"},"Drug":["Abiraterone; Prednisone"],"Gender":"M","Histology":["Adenocarcinoma"],"Mutations":["PTEN"],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9d2"},"case_ID":"DTB-121"}
{"Age":68,"Drug":["Docetaxel"],"Gender":"M","Histology":["Adenocarcinoma"],"Mutations":["TP53"],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9d3"},"case_ID":"DTB-116"}
{"Age":82,"Drug":["Docetaxel; Dexamethasone","Dexamethasone"],"Gender":"M","Gleason":7,"Histology":["Adenocarcinoma"],"Mutations":[],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9d4"},"case_ID":"DTB-117"}
{"Age":71,"Drug":["Enzalutamide"],"Gender":"M","Histology":["No Definite Tumor"],"Mutations":[],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9d5"},"case_ID":"DTB-119"}
{"Age":73,"Date_of_CRPC":{"$date":"2011-10-01T00:00:00.000Z"},"Drug":["Docetaxel"],"Gender":"M","Gleason":9,"Histology":["Adenocarcinoma"],"Mutations":["None"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca9d6"},"case_ID":"DTB-118"}
{"Age":64,"Date_of_CRPC":{"$date":"2014-08-25T00:00:00.000Z"},"Drug":[],"Gender":"M","Gleason":9,"Histology":[],"Mutations":[],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca9d7"},"case_ID":"DTB-120"}
{"Age":61,"Date_of_CRPC":{"$date":"2014-05-20T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":9,"Histology":["Adenocarcinoma"],"Mutations":["None"],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9d8"},"case_ID":"DTB-115"}
{"Age":88,"Date_of_CRPC":{"$date":"2013-02-01T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Histology":[],"Mutations":[],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9d9"},"case_ID":"DTB-123"}
{"Age":72,"Date_of_CRPC":{"$date":"2013-10-25T00:00:00.000Z"},"Drug":["Enzalutamide","Prednisone; Docetaxel"],"Gender":"M","Gleason":9,"Histology":["Adenocarcinoma"],"Mutations":["None"],"Status":"ON FOLLOW UP","_id":{"$oid":"56074312f1f77c0a80eca9da"},"case_ID":"DTB-122"}
{"Age":74,"Date_of_CRPC":{"$date":"2014-05-15T00:00:00.000Z"},"Drug":["Docetaxel"],"Gender":"M","Gleason":7,"Histology":["Adenocarcinoma"],"Mutations":["PTEN"],"Status":"ON FOLLOW UP","_id":{"$oid":"56074312f1f77c0a80eca9db"},"case_ID":"DTB-124"}
{"Age":65,"Date_of_CRPC":{"$date":"2014-03-01T00:00:00.000Z"},"Drug":[],"Gender":"M","Gleason":6,"Histology":["Adenocarcinoma"],"Mutations":["None"],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9dc"},"case_ID":"DTB-125"}
{"Age":90,"Date_of_CRPC":{"$date":"2014-01-27T00:00:00.000Z"},"Drug":["Lupron","Casodex","Enzalutamide","Abiraterone; Prednisone"],"Gender":"M","Gleason":7,"Histology":["Other"],"Mutations":["TP53; FGER1"],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9dd"},"case_ID":"DTB-126"}
{"Age":72,"Date_of_CRPC":{"$date":"2013-09-25T00:00:00.000Z"},"Drug":["Enzalutamide","Enzalutamide"],"Gender":"M","Gleason":8,"Histology":["Other"],"Mutations":["RBI; TP53; TSC2"],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9de"},"case_ID":"DTB-127"}
{"Age":78,"Date_of_CRPC":{"$date":"2014-06-18T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":9,"Histology":["Adenocarcinoma"],"Mutations":["None"],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9df"},"case_ID":"DTB-128"}
{"Age":66,"Date_of_CRPC":{"$date":"2014-09-09T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":6,"Histology":["Other"],"Mutations":["PTEN"],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9e0"},"case_ID":"DTB-129"}
{"Age":65,"Drug":["Enzalutamide"],"Gender":"M","Gleason":8,"Histology":["Other","Other","Other"],"Mutations":["None"],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca9e1"},"case_ID":"DTB-130"}
{"Age":63,"Drug":["Enzalutamide"],"Gender":"M","Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9e2"},"case_ID":"DTB-131"}
{"Age":83,"Date_of_CRPC":{"$date":"2014-06-17T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Histology":["Other"],"Mutations":["None"],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9e3"},"case_ID":"DTB-132"}
{"Age":65,"Drug":["Selinexor"],"Gender":"M","Gleason":7,"Histology":["No Definite Tumor"],"Mutations":[],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca9e4"},"case_ID":"DTB-133"}
{"Age":69,"Drug":["Enzalutamide"],"Gender":"M","Histology":["No Definite Tumor","No Definite Tumor"],"Mutations":[],"Status":"ON FOLLOW UP","_id":{"$oid":"56074312f1f77c0a80eca9e5"},"case_ID":"DTB-134"}
{"Age":79,"Drug":["Abiraterone; Prednisone"],"Gender":"M","Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9e6"},"case_ID":"DTB-136"}
{"Age":57,"Date_of_CRPC":{"$date":"2014-11-25T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Histology":["Other","Other"],"Mutations":["TP53; PTEN","PTEN"],"Status":"ON FOLLOW UP","_id":{"$oid":"56074312f1f77c0a80eca9e7"},"case_ID":"DTB-135"}
{"Age":61,"Date_of_CRPC":{"$date":"2014-11-14T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":9,"Histology":["Adenocarcinoma"],"Mutations":[],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9e8"},"case_ID":"DTB-137"}
{"Age":68,"Date_of_CRPC":{"$date":"2013-09-27T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":7,"Histology":["Adenocarcinoma"],"Mutations":["None"],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9e9"},"case_ID":"DTB-139"}
{"Age":78,"Date_of_CRPC":{"$date":"2015-03-05T00:00:00.000Z"},"Drug":["Docetaxel"],"Gender":"M","Gleason":6,"Histology":["Adenocarcinoma"],"Mutations":["TP53"],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9ea"},"case_ID":"DTB-138"}
{"Age":71,"Date_of_CRPC":{"$date":"2013-12-10T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":8,"Histology":["Other"],"Mutations":["PTEN; NFI"],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9eb"},"case_ID":"DTB-141"}
{"Age":71,"Drug":["Prednisone; Abiraterone"],"Gender":"M","Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9ec"},"case_ID":"DTB-142"}
{"Age":75,"Drug":["Selinexor"],"Gender":"M","Gleason":7,"Histology":["Adenocarcinoma"],"Mutations":[],"Status":"ON FOLLOW UP","_id":{"$oid":"56074312f1f77c0a80eca9ed"},"case_ID":"DTB-140"}
{"Age":64,"Date_of_CRPC":{"$date":"2014-12-12T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":9,"Histology":["Other"],"Mutations":["None"],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9ee"},"case_ID":"DTB-143"}
{"Age":71,"Drug":["Xofigo"],"Gender":"M","Histology":[],"Mutations":[],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9ef"},"case_ID":"DTB-144"}
{"Age":70,"Date_of_CRPC":{"$date":"2014-03-31T00:00:00.000Z"},"Drug":[],"Gender":"M","Histology":["No Definite Tumor"],"Mutations":[],"Status":"ON FOLLOW UP","_id":{"$oid":"56074312f1f77c0a80eca9f0"},"case_ID":"DTB-145"}
{"Age":62,"Date_of_CRPC":{"$date":"2014-02-01T00:00:00.000Z"},"Drug":["Mitoxantrone; Cabazitaxel; Prednisone"],"Gender":"M","Gleason":9,"Histology":["No Definite Tumor"],"Mutations":[],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9f1"},"case_ID":"DTB-147"}
{"Age":60,"Date_of_CRPC":{"$date":"2012-05-08T00:00:00.000Z"},"Drug":["Enzalutamide; Prednisone"],"Gender":"M","Gleason":8,"Histology":["Other"],"Mutations":["EGFR"],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9f2"},"case_ID":"DTB-146"}
{"Age":67,"Date_of_CRPC":{"$date":"2014-11-04T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":8,"Histology":["Other"],"Mutations":["TP53; NTRK2"],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9f3"},"case_ID":"DTB-148"}
{"Age":70,"Date_of_CRPC":{"$date":"2014-07-28T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":9,"Histology":["Adenocarcinoma"],"Mutations":["PIK3R1; STK11; PTEN"],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9f4"},"case_ID":"DTB-149"}
{"Age":68,"Drug":[],"Gender":"M","Histology":[],"Mutations":[],"Status":"OFF STUDY","_id":{"$oid":"56074312f1f77c0a80eca9f5"},"case_ID":"DTB-150"}
{"Age":72,"Date_of_CRPC":{"$date":"2013-12-02T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":9,"Histology":["Adenocarcinoma"],"Mutations":["TP53; NTRK2"],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9f6"},"case_ID":"DTB-151"}
{"Age":78,"Date_of_CRPC":{"$date":"2011-09-01T00:00:00.000Z"},"Drug":["Prednisone; Abiraterone"],"Gender":"M","Gleason":7,"Histology":[],"Mutations":[],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9f7"},"case_ID":"DTB-153"}
{"Age":78,"Drug":["Selinexor"],"Gender":"M","Gleason":8,"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9f8"},"case_ID":"DTB-154"}
{"Age":63,"Drug":[],"Gender":"M","Gleason":9,"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9f9"},"case_ID":"DTB-155"}
{"Age":71,"Date_of_CRPC":{"$date":"2014-02-25T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":7,"Histology":[],"Mutations":[],"Status":"EXPIRED","_id":{"$oid":"56074312f1f77c0a80eca9fa"},"case_ID":"DTB-156"}
{"Age":59,"Drug":["Enzalutamide"],"Gender":"M","Gleason":8,"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9fb"},"case_ID":"DTB-157"}
{"Age":79,"Drug":["Enzalutamide"],"Gender":"M","Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9fc"},"case_ID":"DTB-159"}
{"Age":72,"Date_of_CRPC":{"$date":"2013-11-01T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":8,"Histology":[],"Mutations":[],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9fd"},"case_ID":"DTB-158"}
{"Age":66,"Date_of_CRPC":{"$date":"2014-07-14T00:00:00.000Z"},"Drug":[],"Gender":"M","Histology":[],"Mutations":[],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80eca9fe"},"case_ID":"DTB-161"}
{"Age":87,"Date_of_CRPC":{"$date":"2011-12-01T00:00:00.000Z"},"Drug":["Dexamethasone"],"Gender":"M","Gleason":7,"Histology":["No Definite Tumor"],"Mutations":[],"Status":"ON STUDY","_id":{"$oid":"56074312f1f77c0a80eca9ff"},"case_ID":"DTB-160"}
{"Age":72,"Gender":"M","Gleason":5,"Histology":[],"Mutations":[],"Status":"ON STUDY","_id":{"$oid":"56074312f1f77c0a80ecaa00"},"case_ID":"DTB-162"}
{"Age":79,"Gender":"M","Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80ecaa01"},"case_ID":"DTB-165"}
{"Age":76,"Date_of_CRPC":{"$date":"2013-05-16T00:00:00.000Z"},"Drug":["Enzalutamide"],"Gender":"M","Gleason":7,"Histology":["No Definite Tumor"],"Mutations":[],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80ecaa02"},"case_ID":"DTB-163"}
{"Age":68,"Gender":"M","Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80ecaa03"},"case_ID":"DTB-169"}
{"Age":71,"Date_of_CRPC":{"$date":"1999-02-04T00:00:00.000Z"},"Gender":"M","Gleason":8,"Histology":["Small Cell"],"Mutations":[],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80ecaa04"},"case_ID":"DTB-166"}
{"Age":65,"Date_of_CRPC":{"$date":"2011-11-14T00:00:00.000Z"},"Drug":[],"Gender":"M","Gleason":8,"Histology":["No Definite Tumor"],"Mutations":[],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80ecaa05"},"case_ID":"DTB-168"}
{"Age":64,"Gender":"M","Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80ecaa06"},"case_ID":"DTB-173"}
{"Age":78,"Date_of_CRPC":{"$date":"2008-03-04T00:00:00.000Z"},"Drug":[],"Gender":"M","Gleason":4,"Histology":[],"Mutations":[],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80ecaa07"},"case_ID":"DTB-170"}
{"Age":59,"Gender":"M","Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80ecaa08"},"case_ID":"DTB-174"}
{"Age":71,"Date_of_CRPC":{"$date":"2014-06-01T00:00:00.000Z"},"Gender":"M","Gleason":8,"Histology":[],"Mutations":[],"Status":"ON TREATMENT","_id":{"$oid":"56074312f1f77c0a80ecaa09"},"case_ID":"DTB-171"}
